Immunotherapy Research Continues to Emerge in Urothelial Cancer
Published: Friday, Jul 12, 2019
Robert Dreicer, MD
Approximately one-quarter of patients with urothelial cancer respond to immunotherapy, a number that could increase with better methods to broaden response rates and improve patient selection, explained Robert Dreicer, MD.
... to read the full story